Table 8.
Ciprofloxacin Drug Interactions
| Drug | Cytochrome Association | ↑ Levels/Effects of CYP1A2 Substtates | Dtug-Dtug Intetaction | Renal Impaitment |
|---|---|---|---|---|
| Ciprofloxacin | Inhibits CYP: 1A2 (strong) 3A4 (weak) | aminophylline fluvoxamine mexiletine mirtazapine ropinirole tizanidine trifluoperazine |
Caffeine: may decrease caffeine metabolism Foscatnet: associated with an increased risk of seizures Glybutide: may increase therapeutic effects Methottexate: may decrease renal secretion NSAIDs: risk of seizures may be increased Phenytoin: may decrease levels Ptobenecid: concurrent usage may decrease renal excretion Sevelamet: may decrease oral absorption Theophylline: levels may increase Tizanidine: levels may increase—contraindicated Watfatin: anticoagulant effect may be enhanced Metal cautions (aluminum, calcium, iton, magnesium, and zinc): bind quinolones in the gastrointestinal tract and inhibit absorption |
Caution warranted with renal impairment —dosage adjustment required |
- NSAIDS
nonsteroidal anti-inflammatory drugs.